Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Wire Cambodia.
Press releases published on July 18, 2025
FACT CHECK: Frequency Holdings YCRM Issues Clarification On Procedural Judgment; No Liability to Company, Litigation Exposure Remains for Luciano Aguayo
GlobeNewswire
·
July 18, 2025
CHICAGO, July 17, 2025 (GLOBE NEWSWIRE) -- Frequency Holdings Inc. (OTC: YCRM), a Nevada public company, issues this clarification following a press release distributed on July 17, 2025, by Luciano Aguayo, defendant in the original and now-defunct lawsuit …
Aduro Clean Technologies tritt der Plastics Industry Association und der Polystyrene Recycling Alliance zur Förderung der Branchenzusammenarbeit im Bereich Recycling-Innovationen bei
GlobeNewswire
·
July 18, 2025
LONDON, Ontario, July 18, 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. („Aduro” oder das „Unternehmen”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), ein Unternehmen für saubere Technologien, das die Kraft der Chemie nutzt, um minderwertige Rohstoffe wie …
Aduro Clean Technologies rejoint la Plastics Industry Association et la Polystyrene Recycling Alliance en vue de favoriser la collaboration entre les industries en matière d’innovation dans le domaine du recyclage
GlobeNewswire
·
July 18, 2025
LONDON, Ontario, 18 juill. 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (ci-après « Aduro » ou la « Société ») (Nasdaq : ADUR) (CSE : ACT) (FSE : 9D5), une société de technologie propre qui recycle chimiquement les matières premières de moindre …
SAPU Bioscience Highlights Peer‑Reviewed Publication Linking TGFB2 to Survival in Younger Pancreatic Cancer Patients
GlobeNewswire
·
July 18, 2025
Data supports further evaluation of investigational antisense OT‑101 (trabedersen) as a TGFB2‑targeted approach in pancreatic ductal adenocarcinoma. SAN DIEGO, Calif., July 17, 2025 (GLOBE NEWSWIRE) -- Sapu Biosciences, LLC (Sapu), a wholly owned …
Successful Commercial Launch of Ryoncil®
GlobeNewswire
·
July 18, 2025
NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced gross revenue from sales of Ryoncil® (remestemcel-L-rknd) through the first …